How to classify this AlanR treatment for colds. The main problem is that it is just a home
treatment with no credentials. It works for me and my friends. Thousands of people must have tried it. Over 6,000
Indonesians, about 1700+ people from each of the countries, Hong Kong, the USA,
and Germany for example, almost 18,000 in total, have visited the site. To date, nobody has commented, good or poor.
What is needed is some official standing, a simple clinical trial to determine
What the treatment does is kill the virus in the early stages. It is an enhancement of the very ancient fever immune response using the three parameters heat, humidity and time. The unique part is to temporarily convert the nasal cavity and throat, from a place where the virus replicates, to a virus-killing zone. The process takes about 1.5 - 2 hours. The equivalent that pharmaceutical companies are bringing to market is 3 targeted pills a day for 5 days.
What I am proposing is that a simple trial using my
treatment could be a university medical student-level group project for a term
paper. It would need to have the
blessing of a professor that is comfortable working outside the box and a
student to champion the project. The primary thesis could be that most cold
viruses have a sensitivity limit (mortality) in the range of 37.5 to 39 0C
and relative humidity of > 95% in vivo (references below). To my knowledge,
this has never been done. There could also be a published paper by the prof and
students. This project would be a hands-on medical research experience and a bonus to
any student’s resume.
There is also a very low risk of applying the treatment if
the rules are followed. There are no drugs, no injections, no pain, and no
expensive equipment necessary. The required materials are nose clips or medical
tape, hand sanitizer (for cleaning the oily nose surface), temperature
measuring devices, and PPE supplies, except for the nose clips the above are
readily available at most universities. Side effects: a clear nasal cavity, a
quick recovery (depending on how much damage has been done by the virus).
I have sent notes to
WHO, NIH, CDC, Mayo Clinic, The UN, Canada Health, 5 Universities, the Health
department of 5 provinces, and several clinical doctors. I have had 3 replies,
2 were for permissions to reference their papers. So far, there have been no debunks that I
know of, but the data from my website suggests many referrals.
It is time for me to move on to thoughts about skiing and
leave COVID19 in the background. I live in a small valley beside a salmon
stream. Eagles are patrolling the stream looking for salmon remains from
spawning. Both deer and black bears wander through the two-hector lot on
occasion. Snow is starting to collect higher
up on the mountains to the west. I’ve signed up again as a volunteer ski
instructor with the adaptive snow school group and the mountain opens for
skiing on Dec. 10.
Me, Alan Robb, I’ve been around a university for 11 years as
a student and 10 years as a prof., a research centre for 8 years, and a
consultant for 25 years. If interested
please contact me through my email email@example.com
. I live on the west coast for 7 mo and
5 mo in central Canada.
1. - Why is temperature sensitivity important for the
success of common respiratory viruses? Eccles R., Rev Med
temperature and host species preferences of SARS-CoV-2.
3. -The Effects of Temperature and
Relative Humidity on the Viability of the SARS
K. H. Chan, et al,
4. -Role of fever and ambient temperature in COVID-19
5. -Animal and
translational models of SARS-CoV-2 infection and COVID19
M. D. Johansen1, et al,
Mucosal Immunology (2020) 13:877–891;
-Fever and the thermal regulation of immunity: the immune system feels the
7. Protective Facemask Impact on Human Thermoregulation: An
David Tyrrell, Ian Barrow,
BMJ 002231-0020 1989
Marc Cohen, Extreme wellness Institute, Melbourne, VIC,
Farhad Memarzadeh, PhD,